148 related articles for article (PubMed ID: 9237520)
21. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
Singh J; Desiraju T; Raju TR
Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
[TBL] [Abstract][Full Text] [Related]
22. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
Hurley MJ; Stubbs CM; Jenner P; Marsden CD
Eur J Pharmacol; 1996 Dec; 318(2-3):283-93. PubMed ID: 9016916
[TBL] [Abstract][Full Text] [Related]
23. Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
Seeman P; Van Tol HH
Eur J Pharmacol; 1995 Oct; 291(2):59-66. PubMed ID: 8566176
[TBL] [Abstract][Full Text] [Related]
24. Effects of microinjection of the D2 dopamine antagonist raclopride into the ventral tegmental area on ethanol and sucrose self-administration.
Samson HH; Chappell AM
Alcohol Clin Exp Res; 1999 Mar; 23(3):421-6. PubMed ID: 10195813
[TBL] [Abstract][Full Text] [Related]
25. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
Salmi P; Malmgren K; Svensson TH; Ahlenius S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
[TBL] [Abstract][Full Text] [Related]
27. Neuroleptics and dopamine transporters.
Reader TA; Ase AR; Huang N; Hébert C; van Gelder NM
Neurochem Res; 1998 Jan; 23(1):73-80. PubMed ID: 9482270
[TBL] [Abstract][Full Text] [Related]
28. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
29. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
30. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
Costanza RM; Barber DJ; Terry P
Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
[TBL] [Abstract][Full Text] [Related]
31. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T
Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
33. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
Brudzynski SM; Komadoski M; St Pierre J
Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714
[TBL] [Abstract][Full Text] [Related]
34. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
Merchant KM; Figur LM; Evans DL
Cereb Cortex; 1996; 6(4):561-70. PubMed ID: 8670682
[TBL] [Abstract][Full Text] [Related]
35. Hypothermic effects of dopamine D3 receptor agonists in the island of Calleja Magna. Potentiation by D1 activation.
Barik S; de Beaurepaire R
Pharmacol Biochem Behav; 1998 Jun; 60(2):313-9. PubMed ID: 9632212
[TBL] [Abstract][Full Text] [Related]
36. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
[TBL] [Abstract][Full Text] [Related]
37. Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex.
Kusumi I; Ishikane T; Matsubara S; Koyama T
J Neural Transm Gen Sect; 1995; 101(1-3):231-5. PubMed ID: 8695053
[TBL] [Abstract][Full Text] [Related]
38. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens.
David V; Durkin TP; Cazala P
Psychopharmacology (Berl); 2002 Mar; 160(3):307-17. PubMed ID: 11889500
[TBL] [Abstract][Full Text] [Related]
40. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
